Abstract
Introduction: Studies assessing the impact of preoperative and first-day postoperative values of leukocytes, thrombocytes, and platelet/leukocyte ratio (PLR) after radical cystectomy (RC) are sparse. We aimed to assess the impact of these factors on long-term survival after RC. Methods: An analysis of patients undergoing open RC from 2004 to 2023 at our center was performed. Leukocytosis was defined as ≥8,000 leukocytes/μL and thrombocytosis as ≥400,000 thrombocytes/μL. Similarly, the cutoff for PLR was set at 28. A multivariable Cox regression analysis was performed to assess the role of leukocytosis, thrombocytosis, and PLR on long-term survival after RC. For all analyses, hazard ratios (HRs) with the corresponding 95% confidence intervals (CIs) were estimated. Results: A total of 1,817 patients with a median age of 70 years (interquartile range [IQR]: 62–77) were included. Overall, 804 (44%), 175 (10%), and 1,296 (71%) patients presented with leukocytosis, thrombocytosis, and PLR ≥28 preoperatively. Accordingly, 1,414 (78%), 37 (2%), and 249 (14%) patients presented with leukocytosis, thrombocytosis, and PLR ≥28 on the first day after RC. At a median follow-up of 26 months (IQR: 8–68) after RC, 896 (49%) patients died. In the multivariate Cox regression analysis after adjusting for major perioperative risk factors, only preoperative leukocytosis (HR: 1.3, 95% CI: 1.1–1.6, p = 0.01), as well as both preoperative and first-day thrombocytosis (HR: 2.1, 95% CI: 1.5–2.9, and HR: 2.8, 95% CI: 1.6–5.1, p < 0.001, accordingly) were associated with worse overall survival. Conclusion: PLR should not be used as a prognostic marker for survival after RC. On the contrary, preoperative leukocytosis, as well as preoperative and first-day thrombocytosis should raise awareness among clinicians performing RC since they were independently associated with worse survival after RC.
Journal Section:
Research Article
References
1.
Richters
A
, Aben
KKH
, Kiemeney
LALM
. The global burden of urinary bladder cancer: an update
. World J Urol
. 2020
;38
(8
):1895
–904
. 2.
Witjes
JA
, Bruins
HM
, Cathomas
R
, Compérat
EM
, Cowan
NC
, Gakis
G
, et al. European association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines
. Eur Urol
. 2021
;79
(1
):82
–104
. 3.
Pyrgidis
N
, Sokolakis
I
, Haltmair
G
, Hatzichristodoulou
G
. The short- and long-term effect of radical cystectomy in frail patients with bladder cancer
. Clin Genitourin Cancer
. 2023
;21
(4
):e291
–8
. 4.
Katsimperis
S
, Tzelves
L
, Tandogdu
Z
, Ta
A
, Geraghty
R
, Bellos
T
, et al. Complications after radical cystectomy: a systematic review and meta-analysis of randomized controlled trials with a meta-regression analysis
. Eur Urol Focus
. 2023
;9
(6
):920
–9
. 5.
Tamalunas
A
, Buchner
A
, Kretschmer
A
, Jokisch
F
, Schulz
G
, Eismann
L
, et al. Impact of routine laboratory parameters in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: a long-term follow-up
. Urol Int
. 2020
;104
(7–8
):551
–8
. 6.
Lobo
N
, Mount
C
, Omar
K
, Nair
R
, Thurairaja
R
, Khan
MS
. Landmarks in the treatment of muscle-invasive bladder cancer
. Nat Rev Urol
. 2017
;14
(9
):565
–74
. 7.
Pyrgidis
N
, Volz
Y
, Ebner
B
, Kazmierczak
PM
, Enzinger
B
, Hermans
J
, et al. The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: results of the German nationwide inpatient data
. World J Urol
. 2024
;42
(1
):19
. 8.
Pyrgidis
N
, Sokolakis
I
, Haltmair
G
, Hatzichristodoulou
G
. The effect of urinary diversion on renal function after cystectomy for bladder cancer: comparison between ileal conduit, orthotopic ileal neobladder, and heterotopic ileocecal pouch
. World J Urol
. 2022
;40
(12
):3091
–7
. 9.
Masson-Lecomte
A
, Rava
M
, Real
FX
, Hartmann
A
, Allory
Y
, Malats
N
. Inflammatory biomarkers and bladder cancer prognosis: a systematic review
. Eur Urol
. 2014
;66
(6
):1078
–91
. 10.
Chakra
MA
, Azoulai
D
, Moussa
M
, Ismail
K
, Peyromaure
M
, Delongchamps
NB
, et al. The prognostic role of pre-cystectomy thrombocytosis in invasive bladder cancer
. Int Urol Nephrol
. 2022
;54
(12
):3153
–61
. 11.
Moschini
M
, Suardi
N
, Pellucchi
F
, Rocchini
L
, La Croce
G
, Capitanio
U
, et al. Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma
. Anticancer Res
. 2014
;34
(6
):3225
–30
.12.
Kluth
LA
, Xylinas
E
, Rieken
M
, Kent
M
, Ikeda
M
, Matsumoto
K
, et al. Prognostic model for predicting survival in patients with disease recurrence following radical cystectomy
. Eur Urol Focus
. 2015
;1
:75
–81
. 13.
Schulz
GB
, Grimm
T
, Buchner
A
, Jokisch
F
, Grabbert
M
, Schneevoigt
B-S
, et al. Prognostic value of the preoperative platelet-to-leukocyte ratio for oncologic outcomes in patients undergoing radical cystectomy for bladder cancer
. Clin Genitourin Cancer
. 2017
;15
(6
):e915
–21
. 14.
von Elm
E
, Altman
DG
, Egger
M
, Pocock
SJ
, Gøtzsche
PC
, Vandenbroucke
JP
, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
. Lancet Lond Engl
. 2007
;370
(9596
):1453
–7
. 15.
Giannarini
G
, Kessler
TM
, Thoeny
HC
, Nguyen
DP
, Meissner
C
, Studer
UE
. Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution
. Eur Urol
. 2010
;58
(4
):486
–94
. 16.
Jokisch
J-F
, Grimm
T
, Buchner
A
, Kretschmer
A
, Weinhold
P
, Stief
CG
, et al. Preoperative thrombocytosis in patients undergoing radical cystectomy for urothelial cancer of the bladder: an independent prognostic parameter for an impaired oncological outcome
. Urol Int
. 2020
;104
(1–2
):36
–41
. 17.
Mitropoulos
D
, Artibani
W
, Biyani
CS
, Bjerggaard Jensen
J
, Rouprêt
M
, Truss
M
. Validation of the clavien-dindo grading system in Urology by the European association of Urology guidelines ad hoc panel
. Eur Urol Focus
. 2018
;4
:608
–13
. 18.
Moghadamyeghaneh
Z
, Hanna
MH
, Carmichael
JC
, Mills
SD
, Pigazzi
A
, Stamos
MJ
. Preoperative leukocytosis in colorectal cancer patients
. J Am Coll Surg
. 2015
;221
(1
):207
–14
. 19.
Mabuchi
S
, Matsumoto
Y
, Isohashi
F
, Yoshioka
Y
, Ohashi
H
, Morii
E
, et al. Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer
. Gynecol Oncol
. 2011
;122
(1
):25
–32
. 20.
Tavakkoli
M
, Wilkins
CR
, Mones
JV
, Mauro
MJ
. A novel paradigm between leukocytosis, G-CSF secretion, neutrophil-to-lymphocyte ratio, myeloid-derived suppressor cells, and prognosis in non-small cell lung cancer
. Front Oncol
. 2019
;9
:295
. 21.
Ozcan
C
, Telli
O
, Ozturk
E
, Suer
E
, Gokce
MI
, Gulpinar
O
, et al. The prognostic significance of preoperative leukocytosis and neutrophil-to-lymphocyte ratio in patients who underwent radical cystectomy for bladder cancer
. Can Urol Assoc J J Assoc Urol Can
. 2015
;9
(11–12
):E789
–794
. 22.
Shaul
ME
, Fridlender
ZG
. Tumour-associated neutrophils in patients with cancer
. Nat Rev Clin Oncol
. 2019
;16
(10
):601
–20
. 23.
Sasaki
K
, Kawai
K
, Tsuno
NH
, Sunami
E
, Kitayama
J
. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer
. World J Surg
. 2012
;36
(1
):192
–200
. 24.
Pedersen
LM
, Milman
N
. Prognostic significance of thrombocytosis in patients with primary lung cancer
. Eur Respir J
. 1996
;9
:1826
–30
. 25.
Stone
RL
, Nick
AM
, McNeish
IA
, Balkwill
F
, Han
HD
, Bottsford-Miller
J
, et al. Paraneoplastic thrombocytosis in ovarian cancer
. N Engl J Med
. 2012
;366
(7
):610
–8
. 26.
Menter
DG
, Tucker
SC
, Kopetz
S
, Sood
AK
, Crissman
JD
, Honn
KV
. Platelets and cancer: a casual or causal relationship: revisited
. Cancer Metastasis Rev
. 2014
;33
(1
):231
–69
. 27.
Pinedo
HM
, Verheul
HM
, D’Amato
RJ
, Folkman
J
. Involvement of platelets in tumour angiogenesis
. Lancet Lond Engl
. 1998
;352
(9142
):1775
–7
. 28.
Gay
LJ
, Felding-Habermann
B
. Contribution of platelets to tumour metastasis
. Nat Rev Cancer
. 2011
;11
(2
):123
–34
. 29.
Todenhöfer
T
, Renninger
M
, Schwentner
C
, Stenzl
A
, Gakis
G
. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors
. BJU Int
. 2012
;110
(11 Pt B
):E533
–540
. 30.
Ebner
B
, Fleckenstein
F
, Volz
Y
, Eismann
L
, Hermans
J
, Buchner
A
, et al. Oncological impact of perioperative blood transfusion in bladder cancer patients undergoing radical cystectomy: do we need to consider storage time of blood units, donor age, or gender matching
. Transfus Paris
. 2024
;64
(1
):29
–38
. 31.
Volz
Y
, Eismann
L
, Pfitzinger
PL
, Jokisch
J-F
, Buchner
A
, Schlenker
B
, et al. Prognostic impact of perioperative blood transfusions on oncological outcomes of patients with bladder cancer undergoing radical cystectomy: a systematic review
. Arab J Urol
. 2020
;19
(1
):24
–30
. 32.
Yoshida
T
, Kinoshita
H
, Yoshida
K
, Mishima
T
, Yanishi
M
, Inui
H
, et al. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy
. Tumour Biol
. 2016
;37
(8
):10067
–74
. 33.
Herzberg
H
, Lifshitz
K
, Golan
S
, Baniel
J
, Malshy
K
, Hoffman
A
, et al. Association between early change in neutrophil-to-lymphocyte ratio after radical cystectomy and treatment outcomes
. BJU Int
. 2022
;130
(4
):470
–7
. 34.
Wang
R
, Yan
Y
, Liu
S
, Yao
X
. Comparison of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios in bladder cancer patients undergoing radical cystectomy
. Biomed Res Int
. 2019
;2019
:3628384
. 35.
Lei
Y
, Jiao
D
, Yao
Z
, Wang
L
, Zhao
Z
. Prognostic values of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte- to-monocyte ratio for patients with muscle-invasive bladder cancer undergoing radical cystectomy
. Arch Esp Urol
. 2022
;75
(3
):287
–94
.36.
Ofner
H
, Laukhtina
E
, Hassler
MR
, Shariat
SF
. Blood-based biomarkers as prognostic factors of recurrent disease after radical cystectomy: a systematic review and meta-analysis
. Int J Mol Sci
. 2023
;24
(6
):5846
. 37.
Li
X
, Dai
D
, Chen
B
, Tang
H
, Xie
X
, Wei
W
. The value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: a systematic review and meta-analysis
. J Cancer
. 2018
;9
(5
):861
–71
. 38.
Pyrgidis
N
, Sokolakis
I
, Haltmair
G
, Hatzichristodoulou
G
. The perioperative and long-term outcomes of patients with variant histology bladder cancer undergoing radical cystectomy: a propensity score-matched analysis with pure urothelial carcinoma
. Actas Urol Esp
. 2023
;47
(10
):645
–53
. 39.
Volz
Y
, Pfitzinger
PL
, Eismann
L
, Ebner
B
, Jokisch
F
, Schulz
GB
, et al. Prognostic value of pretreatment inflammatory markers in patients receiving radical cystectomy for urothelial bladder cancer: does age matter
. Urol Int
. 2022
;106
(8
):832
–9
. 40.
Zhang
W
, Yang
F
, Kadier
A
, Chen
Y
, Yu
Y
, Zhang
J
, et al. Development of nomograms related to inflammatory biomarkers to estimate the prognosis of bladder cancer after radical cystectomy
. Ann Transl Med
. 2021
;9
(18
):1440
. 41.
Viers
BR
, Boorjian
SA
, Frank
I
, Tarrell
RF
, Thapa
P
, Karnes
RJ
, et al. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy
. Eur Urol
. 2014
;66
(6
):1157
–64
. 42.
Peng
D
, Zhang
C-J
, Gong
Y-Q
, Hao
H
, Guan
B
, Li
X-S
, et al. Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy
. Sci Rep
. 2018
;8
(1
):794
. 43.
Gakis
G
, Todenhöfer
T
, Stenzl
A
. The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer
. Curr Opin Urol
. 2011
;21
(5
):428
–33
. 44.
Pyrgidis
N
, Schulz
GB
, Volz
Y
, Ebner
B
, Rodler
S
, Westhofen
T
, et al. The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study
. World J Urol
. 2024
;42
(1
):164
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
